The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies
- PMID: 33387619
- PMCID: PMC7837102
- DOI: 10.1016/j.avsg.2020.12.006
The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies
Figures

Comment on
-
Early experience with arterial thromboembolic complications in patients with COVID-19.J Vasc Surg. 2021 Feb;73(2):381-389.e1. doi: 10.1016/j.jvs.2020.07.089. Epub 2020 Aug 28. J Vasc Surg. 2021. PMID: 32861865 Free PMC article.
Similar articles
-
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.Front Immunol. 2022 Sep 15;13:953043. doi: 10.3389/fimmu.2022.953043. eCollection 2022. Front Immunol. 2022. PMID: 36189273 Free PMC article.
-
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372. Int J Mol Sci. 2022. PMID: 36142282 Free PMC article. Review.
-
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers.Front Immunol. 2022 Jul 15;13:930074. doi: 10.3389/fimmu.2022.930074. eCollection 2022. Front Immunol. 2022. PMID: 35911726 Free PMC article.
-
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.Lupus. 2022 Jul;31(8):974-984. doi: 10.1177/09612033221102073. Epub 2022 May 20. Lupus. 2022. PMID: 35593174 Free PMC article.
-
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6. Thorax. 2021. PMID: 33408195 Review.
Cited by
-
Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts.PLoS One. 2025 Jun 4;20(6):e0324513. doi: 10.1371/journal.pone.0324513. eCollection 2025. PLoS One. 2025. PMID: 40465573 Free PMC article.
-
Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome.J Thromb Thrombolysis. 2021 Nov;52(4):1043-1046. doi: 10.1007/s11239-021-02444-0. Epub 2021 Apr 12. J Thromb Thrombolysis. 2021. PMID: 33844151 Free PMC article.
-
Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications.Innov Clin Neurosci. 2022 Jan-Mar;19(1-3):19-25. Innov Clin Neurosci. 2022. PMID: 35382075 Free PMC article.
-
Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation.Prostaglandins Other Lipid Mediat. 2021 Jun;154:106540. doi: 10.1016/j.prostaglandins.2021.106540. Epub 2021 Feb 23. Prostaglandins Other Lipid Mediat. 2021. PMID: 33636368 Free PMC article. Review.
-
The Impact of COVID-19 Infection on Abdominal Aortic Aneurysms: Mechanisms and Clinical Implications.Cardiovasc Ther. 2024 Jul 29;2024:7288798. doi: 10.1155/2024/7288798. eCollection 2024. Cardiovasc Ther. 2024. PMID: 39742024 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical